Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

Group 1 - Orion Corporation has received a notification regarding a transaction involving shares by Maziar Mike Doustdar, a member of the Board [1] - The transaction occurred on April 30, 2025, involving 415 shares at a unit price of 0 EUR, categorized as a receipt of a share-based incentive [1] - The company operates in the pharmaceutical sector, focusing on human and veterinary pharmaceuticals, with a strong emphasis on oncology and pain management [2] Group 2 - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] - Orion's shares are listed on Nasdaq Helsinki, indicating its presence in the public market [2]